| Ytd | 218.57% | |
| 1y | 650.63% |
| Open | 11.95 | Prev Close | 11.70 | Low | 11.61 | High | 12.21 | Mkt Cap | 2.23B |
| Vol | 5.12M | Avg Vol | 9.83M | EPS | -0.23 | P/E | -52.22 | Forward P/E | -102.08 |
| Beta | 2.42 | Short Ratio | 6.31 | Inst. Own | 27.82% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 10.82 | 200-d Avg | 5.64 | 1yr Est | 27.50 |
SLS News
SELLAS Life Sciences enters its pivotal REGAL readout with a transformed shareholder base, stronger
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
Gainers Jasper Therapeutics (NASDAQ:JSPR) stock moved upwards by 19.2% to $0.92 during Friday's
US stocks lower, Nasdaq falls 400 pts. ManpowerGroup shares rise after upbeat earnings. Other big ga
SELLAS Life Sciences is at the center of a debate over its event-driven Phase 3 REGAL trial for GPS
SELLAS Life Sciences Group Inc (NASDAQ:SLS) shares are trading lower Wednesday as investors take pro
SELLAS Life Sciences Group Inc (NASDAQ:SLS) shares are trading lower Tuesday as traders digest the r
[url="]Amentum[/url] (NYSE: AMTM), a global leader in advanced engineering and technology solutions,
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
Dow Jones gains 350 points, Iridium acquired by Rocket Lab for $8B, big stocks recording gains: Quid
SELLAS Life Sciences is advancing a dual-path AML franchise with GPS nearing pivotal Phase 3 REGAL r
Sellas Life Sciences (SLS) shares are extending gains on Jun. 26 following a key regulatory filing t
SELLAS Life Sciences Group Inc (NASDAQ:SLS) shares are pushing higher Friday morning, adding to Thur
Apogee Enterprises Inc (NASDAQ: APOG) rose sharply after the company reported better-than-expected f
Shares of SELLAS Life Sciences Group Inc. (NASDAQ:SLS) are rallying sharply Thursday, hitting a fres
Sellas Life Sciences Group Inc (NASDAQ:SLS) shares are trading higher on Wednesday as traders react
NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS”
SELLAS Life Sciences Group Inc. (NASDAQ:SLS) reported first-quarter (Q1) 2026 financial results on T
– Contract Research Organization for the Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acut
U.S. stocks were lower, Dow Jones fell 0.1% on Monday. XOMA shares rose on Ligand's plans to acq
SELLAS Life Sciences is rated 'Hold' due to pending phase 3 REGAL data for GPS in AML after CR2, a m
The mean of analysts' price targets for SELLAS Life Sciences Group, Inc. (SLS) points to a 66.1% ups
SELLAS Life Sciences Group, Inc. (SLS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growin
The consensus price target hints at a 63.6% upside potential for SELLAS Life Sciences Group, Inc. (S
SELLAS Life Sciences Group, Inc. (NASDAQ: SLS - Get Free Report) shares gapped up before the market
A late-stage clinical biopharmaceutical company focused on immunotherapy for various cancers, SELLAS
SELLAS Life Sciences Group (NASDAQ: SLS - Get Free Report) and Dianthus Therapeutics (NASDAQ: DNTH -
On Friday, 469 companies hit new 52-week lows.
On Wednesday, 807 companies reached new 52-week lows.
On Friday, 1043 companies hit new 52-week lows.
Gainers HighPoint Resources Corporation (NYSE: HPR) shares jumped 118.8% to close at $10.83 on We